ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

Overview | Financials
Company Name ACADIA Pharmaceuticals Inc.
Symbol ACAD
Currency USD
Price 16.9
Market Cap 2,812,024,800
Dividend Yield 0%
52-week-range 14.15 - 29.29
Industry Biotechnology
Sector Healthcare
CEO Mr. Stephen R. Davis J.D.
Website https://www.acadia-pharm.com

An error occurred while fetching data.

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3

Related Stocks

Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc.

HRMY

36.42 USD

Privia Health Group, Inc. logo

Privia Health Group, Inc.

PRVA

21 USD

AdaptHealth Corp. logo

AdaptHealth Corp.

AHCO

10.37 USD

Roivant Sciences Ltd. logo

Roivant Sciences Ltd.

ROIV

10.94 USD

Axonics, Inc. logo

Axonics, Inc.

AXNX

70.98 USD

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

18.74 USD

Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc.

PCRX

20.55 USD

OPKO Health, Inc. logo

OPKO Health, Inc.

OPK

1.48 USD

Insmed Incorporated logo

Insmed Incorporated

INSM

68.29 USD

Financials

Numbers are in millions USD

Numbers are in millions USD